Depletion of colonic detoxication enzyme activity in mice with dextran sulphate sodium-induced colitis

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 3, 1999, Pages 389-396

  Clapper, M L ^a   Adrian, R H ^a   Pfeiffer, G R ^a   Kido, K ^b   Everley, L ^a   Cooper, H S ^a   Murthy, S ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE TRANSFERASE; INTESTINE ENZYME; ISOENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; COLON; COLORECTAL CANCER; CONTROLLED STUDY; DETOXIFICATION; DISEASE COURSE; DISEASE MARKER; ENZYME ACTIVITY; IMMUNOBLOTTING; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, NORTHERN; BLOTTING, WESTERN; COLITIS; COLON; COLONIC NEOPLASMS; DEXTRAN SULFATE; FEMALE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MICE;

EID: 0032995913     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00475.x     Document Type: Article

References (34)

1. 1 American Cancer Society. Cancer Facts and Figures - 1996. Atlanta, GA: American Cancer Society, 1996.
2. 2 Lashner BA, Hanauer SB, Silverstein MD. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis. Ann Intern Med 1988; 108: 274-8.
3. 3 Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol 1996; 91: 44-8.
4. 4 Ohkusa T. Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and change in intestinal microflora. Jpn J Gastroenterol 1985; 82: 1327-36.
5. 5 Okayasu I, Hatekayama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
6. 6 Cooper HS, Murthy SNS, Shah RS, Sedergran DJ. Clinico-pathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238-49.
7. 7 Cooper HS, Murthy SNS. Dysplasia in dextran sulfate sodium (DSS) experimental murine colitis. Gastroenterology 1994; 106: A 378(Abstract).
8. 8 Yamada M, Ohkusa T, Okayasu I. Occurrence of dysplasia and adenocarcinoma after experimental colitis in hamsters induced by dextran sulfate sodium. Gut 1992; 33: 1521-7.
9. 9 Okayasu I, Ohkusa T, Kajiura J, Sakamoto S. Promotion of colorectal neoplasia in experimental murine colitis. Gut 1996; 39: 87-92.
10. 10 Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Molec Biol 1995; 30: 445-600.
11. 11 Szarka CE, Pfeiffer GR, Hum ST, et al. Glutathione S-transferase activity and glutathione S-transferase μ expression in subjects with risk for colorectal cancer. Cancer Res 1995; 55: 2789-93.
12. 12 Hertervig E, Nilsson Å, Seidegård J. The expression of glutathione transferase μ in patients with inflammatory bowel disease. Scand J Gastroenterol 1994; 29: 729-35.
13. 13 Duncan H, Swan C, Green J, et al. Susceptibility to ulcerative colitis and Crohn's disease: Interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clin Chim Acta 1995; 240: 53-61.
14. 14 Seidegård J, Pero RW, Miller DG, Beattie EJ. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986; 7: 751-3.
15. 15 Lafuente A, Pujol F, Carretero P, Villa JP, Cuchi A. Human glutathione S-transferase μ (GSTμ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 1993; 68: 49-54.
16. 16 Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85: 1159-64.
17. 17 Murthy SNS, Cooper HS, Shim H, Shah RS, Ibrahim S, Sedergran D. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993; 38: 1722-34.
18. 18 Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases - the first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-9.
19. 19 Seelig GF, Meister A. Glutathione biosynthesis; γ-glutamylcysteine synthetase from rat kidney. Meth Enzymol 1985; 113: 379-90.
20. 20 Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinyl pyridine. Anal Biochem 1980; 106: 207-12.
21. 21 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
22. 22 Clapper ML, Tew KD. Identification of a glutathione S-transferase associated with microsomes of tumor cells resistant to nitrogen mustard. Biochem Pharmacol 1989; 38: 1915-21.
23. 23 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
24. 24 Townsend AJ, Goldsmith ME, Pickett CB, Cowan KH. Isolation, characterization, and expression in Escherichia coli of two murine mu class glutathione S-transferase cDNAs homologous to the rat subunits 3 (Yb1) and 4 (Yb2). J Biol Chem 1989; 264: 21582-90.
25. 25 Rajchel A, Chan YL, Woll IG. The primary structure of rat ribosomal protein L32. Nucl Acids Res 1988; 16: 2347.
26. 26 Inauen W, Bilzer M, Rowedder E, Halter F, Lauterburg BH. Decreased glutathione (GSH) in colonic mucosa of patients with inflammatory bowel disease (IBD): Mediated by oxygen free radicals? Gastroenterology 1988; 94: A199(Abstract).
27. 27 Bhaskar L, Ramakrishna BS, Balasubramanian KA. Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis. J Gastroenterol Hepatol 1995; 10: 140-3.
28. 28 Conner EM, Brand SJ, Davis JM, Kang DY, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. Inflam Bowel Dis 1996; 2: 133-47.
29. 29 Ansher SS, Dolan P, Bueding E. Biochemical effects of dithiolthiones. Food Chem Toxicol 1986; 24: 405-15.
30. 30 Davies MH, Blacker AM, Schnell RC. Dithiolthione-induced alterations in hepatic glutathione and related enzymes in male mice. Biochem Pharmacol 1987; 36: 568-70.
31. 31 Clapper ML, Everley LC, Strobel LA, Townsend AJ, Engstrom PF. Coordinate induction of glutathione S-transferase α, μ, and π expression in murine liver after a single administration of oltipraz. Mol Pharmacol 1994; 45: 469-74.
32. 32 O'Dwyer PJ, Szarka CE, Yao K-S, et al. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J Clin Invest 1996; 98: 1210-17.
33. 33 Rao CV, Tokomo K, Kelloff G, Reddy BS. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis 1991; 12: 1051-5.
34. 34 Rao CV, Rivenson A, Katiwalla M, Kelloff GJ, Reddy BS. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res 1993; 53: 2502-6.